Josh Johnston, OD, FAAO, evaluates the nuances integral to success with new technology for premium cataract surgery. He is the clinical and residency director at Georgia Eye Partners in Atlanta. Johnston reports he is a consultant to Alcon, Allergan, Bio-Tissue, Johnson & Johnson Vision and Shire.

BLOG: Toward fewer bad surprises

June 15, 2018

A refractive surprise after cataract surgery is a dreaded outcome for the surgeon and, more importantly, a satisfaction killer for patients. No matter what type of…

BLOG: Astigmatism correction essential to 20/happy cataract outcomes

May 14, 2018

We know that today’s cataract surgery is truly refractive cataract surgery. As such, patients expect refractive type outcomes after the procedure. Therefore, more…

BLOG: Why ODs should comanage cataract surgery

April 12, 2018

The sheer numbers provide much of the obvious evidence of why optometrists need to be involved in the comanagement of cataract surgery. Currently, about 3 million…